● Recruiting

A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity

Condition: Obesity · Sponsor: AbbVie

PhasePhase 1

Planned participants48

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

This study is to assess adverse events, change in body weight and pharmacokinetics in adult participants with obesity receiving ABBV-295 subcutaneous injections or matching placebo.

This description comes directly from the study's public registry record.

Talk to the study team

ABBVIE CALL CENTER · 844-663-3742 · abbvieclinicaltrials@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (2)

CenExel ACT- Anaheim Clinical Trials /ID# 283200	Anaheim, California, United States	Recruiting
Acpru /Id# 278624	Grayslake, Illinois, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07291232